Carrier dependent cell differentiation of bone morphogenetic protein-2 induced osteogenesis and chondrogenesis during the early implantation stage in rats

Journal of Biomedical Materials Research - Part A

Volumn 71, Issue 1, 2004, Pages 181-189

  Takita, H ^a   Vehof, J W M ^b   Jansen, J A ^b   Yamamoto, M ^c   Tabata, Y ^c   Tamura, M ^a   Kuboki, Y ^a,d  

^a HOKKAIDO UNIVERSITY   (Japan)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c KYOTO UNIVERSITY   (Japan)

^d KOKEN Co Ltd   (Japan)

Author keywords

Bone morphogenetic protein; Carrier geometry; Chondrogenesis; Osteogenesis; Vascularization

Indexed keywords

CELLS; FIBROUS MEMBRANES; GLASS; IMPLANTS (SURGICAL);

DISTINCT CARRIERS; FIBROUS GLASS MEMBRANES; MORPHOGENETIC PROTEINS; OSTEOINDUCTIVE EFFECTS;

COLLAGEN;

ALKALINE PHOSPHATASE; DRUG CARRIER; GLASS FIBER; MESSENGER RNA; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; VASCULOTROPIN;

ANIMAL EXPERIMENT; ARTICLE; BONE DEVELOPMENT; BONE MATRIX; CALCIFICATION; CALCIUM TRANSPORT; CHONDROGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DEVELOPMENTAL STAGE; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG RELEASE; DRUG RETENTION; DRUG SCREENING; ENZYME ACTIVITY; IMPLANTATION; MOUSE; NIDATION; NONHUMAN; PARTICLE SIZE; PROTEIN EXPRESSION; SOLUBILIZATION; STATISTICAL SIGNIFICANCE;

ALKALINE PHOSPHATASE; ANIMALS; BONE MATRIX; BONE MORPHOGENETIC PROTEINS; CALCIUM; CELL DIFFERENTIATION; CHONDROGENESIS; DRUG CARRIERS; GLASS; HUMANS; IODINE RADIOISOTOPES; MALE; MICE; MICROSCOPY, ELECTRON; OSTEOCALCIN; OSTEOGENESIS; PARTICLE SIZE; PROSTHESES AND IMPLANTS; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 4544247000     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.a.30152     Document Type: Article

References (40)

1. Wozney JM. The bone morphogenetic protein family and osteogenesis. Mol Reprod Dev 1992;32:160-167.
2. Wozney JM, Rosen V, Celest AJ, Mitsock LM, Whitters MJ, Kriz RW, Hiwick RM, Wang EA. Novel regulators of bone formation. Science 1988;242:1528-1534.
3. Wang EA, Rosen V, D'Alessandro JS, Bauduy M, Cordes P, Harada T, Israel DI, Hewick R, Kerns KM, Lapan P, Luxenberg DP, Mcquaid D, Moutsatsos IK, Nove J, Wozney JM. Recombinant human bone morphogenetic protein induces bone formation. Proc. Natl Acad Sci U S A 1990;87:2220-2224.
4. Ebara S, Nakayama K. Mechanism for the action of bone morphogenetic proteins and regulation of their activity. Spine 2002;27:S10-S15.
5. Yamamoto M, Tabata Y, Ikada Y. Ectopic bone formation induced by biodegradable hydrogels incorporating bone morphogenetic protein. J Biomater Sci Polymer Ed 1998;9:439-458.
6. Sampath TK, Reddi AH. Dissociative extraction and reconstruction of extracellular matrix components involved in local bone differentiation. Proc Natl Acad Sci U S A 1981;78:7599-7603.
7. Seeherman H, Wozney J, Li R. Bone morphogenetic protein delivery systems. Spine 2002;27:S16-S23.
8. Uludag H, Augusta DD, Palmer R, Timony G. Wozney J. Characterization of rhBMP-2 pharmacokinetics implanted with biomaterial carriers in the rat ectopic model. J Biomed Mater Res 1999;46:193-202.
9. Uludag H, Gao T, Porter TJ, Friess W, Wozney JM. Delivery systems for BMPs: factors contributing to protein retention at an application site. J Bone Joint Surg 2001;83A:S128-135.
10. Kuboki Y, Saito T, Murata M, Takita H, Mizuno M, Inoue M, Nagai N, Pool R. Two distinctive BMP-carriers induce zonal chondrogenesis and membranous ossification, respectively; geometrical factors of matrices for cell-differentiation. Connect Tissue Res 1995;32:219-226.
11. van der Lubbe HB, Klein CP, de Groot K. A simple method for preparing thin (10 microM) histological sections of undecalcified plastic embedded bone with implants. Stain Technol 1988; 63:171.
12. Connerty HV, Briggs AR. Determination of serum calcium by means of orthocresolphthalein complexone. J Clin Path 1966; 45:290-296.
13. Kind PRN, King EJ. Estimation of plasma phosphate by determination of hydrolizes phenol with amino-antipyrine. J Clin Pathol 1954;7:322-326.
14. Reginato AM, Jimenez SA. Biochemical characterization of the native tissue form of type X collagen from embryonic chick sternal cartilage and identification of a chymotrypsin-sensitivity site within its triple-helical domain. Biochem J 1991;273:333-338.
15. Takita H, Kikuchi M, Sato Y, Kuboki Y. Inhibition of BMP-induced ectopic bone formation by an antiangiogenic agent (epigallocatechin-3-gallate). Connect Tissue Res 2002;43:520-523.
16. Mahmood J, Takita H, Ojima Y, Kobayashi M, Kohgo T, Kuboki Y. Geometric effect of matrix upon cell differentiation: BMP-induced osteogenesis using a new bioglass with a feasible structure. J Biochem 2001;129:163-171.
17. Bible G, Robers E, Birch M, Evans DB. PCR phenotyping of cytokines, growth factors and their receptors and bone matrix proteins in human osteoblast-like cell line. Bone 1996;19:437-445.
18. Yeh L-CC, Lee JC. Osteogenic protein-1 increases gene expression of vascular endothelial growth factor in primary cultures of fetal rat calvaria cells. Mol Cell Endocrinol 1999;153:113-124.
19. Fort P, Marty L, Piechaczyk M, Sabrouty S, Dani C, Jeanteur P, Blanchard JM. Various rat adult express only one major mRNA species from the glyceraldehydes-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res 1985;13:1431-1442.
20. 125I-labeled human growth hormone of high specific radioactivity. Biochem J 1963;89:114-123.
21. Urist MR, Huo YK, Brownell AG, Hohl WM, Buyske J, Lietze A, Tempst P, Hunkapiller M, DeLange RJ. Purification of bovine bone morphogenetic protein by hydroxyapatite chromatography. Proc Natl Acad Sci U S A 1984;81:371-375.
22. Reddi AH. Cell biology and biochemistry of endochondral bone development. Coll Res 1981;1:209-226.
23. Takita H, Tsuruga E, Ono I, Kuboki Y. Enhancement by bFGF of ostogenesis induced by rhBMP-2 in rats. Eur J Oral Sci 1997;105:588-592.
24. Gundberg CM, Hauschka PV, Lian JB, Gallop PM. Osteocalcin: isolation, characterization, and detection. Methods Enzymol 1984;107:516-544.
25. 2+-binding protein of bone matrix. Haemostasis 1986;16:258-272.
26. Yang BB, Zhang Y, Cao L, Yang BL. Aggrecan and link protein affect cell adhesion to culture plates and to type II collagen. Matrix Biol 1998;17:379-392.
27. Risau W. Mechanisms of angiogenesis. Nature 1997;386:671-674.
28. Olofsson B, Korpelainen E, Pepper MS, Mandriota SJ, Aase K, Kumar V, Gunji Y, Jeltsch MM, Shibuya M, Alitalo K, Eriksson U. Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells. Proc Natl Acad Sci U S A 1998;95:11709-11714.
29. Achen MG, Jeltsch M, Kukk E, Makinen T, Vitali A, Wilks AF, Alitalo K, Stacker SA. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk-1) and VEGF receptor 3 (Flk 4). Proc Natl Acad Sci U S A 1998;95:548-553.
30. Deckers MML, Bezooljen RL, Horst G, Hoogendam J, Bent C, Papapoulos SE, Lowik CWGM. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 2002;143:1545-1553.
31. Lind M, Eriksen EF, Bunger C. Bone morphogenetic protein-2 but not bone morphogenetic protein-4 and -6 stimulates chemotactic migration of human osteoblast, human marrow osteoblasts, and U2-OS cells. Bone 1996;18:53-57.
32. Cunningham NS, Parakar V, Reddi AH. Osteogenin and recombinant bone morphogenetic protein 2B are chemotactic for human monocytes and stimulate transforming growth factor beta 1 mRNA expression. Proc Natl Acad Sci U S A 1992;89:11740-11744.
33. Winn SR, Uludag H, Hollinger JO. Carrier systems for bone morphogenetic proteins. Clin Orthop 1999;367(Suppl):S95-106.
34. Uludag H, Norrie B, Kousinioris N, Gao T. Engineering temperature-sensitive poly (N-isopropylacrylamide) polymers as carriers of therapeutic proteins. Biotecnol Bioeng 2001;73:510-521.
35. Takaoka K, Nakahara H, Yoshikawa H, Masuhara K, Tsuda T, Ono K. Ectopic bone induction on and in porous hydroxyapatite combined with collagen and bone morphogenetic protein. Clin Orthop 1988;234:250-254.
36. Laffargue P, Hildebrand HF, Rtaimate M, Frayssinet P, Amoureux JP, Marchandise X. Evaluation of human recombinant bone morphogenetic protein-2-loaded tricalcium phosphate implants in rabbit's bone defects. Bone 1999;25(Suppl 2):55S-58S.
37. Sasano Y, Ohtani E, Narita K, Kagayama M, Murata M, Saito T, Shigenobu K, Takita H, Mizuno M, Kuboki Y. BMPs induce direct bone formation in ectopic sites independent of the endochondral ossification in vivo. Anat Rec 1993;236:373-380.
38. Kuboki Y, Takita H, Kobayashi D, Tsuruga E, Inoue M, Murata M, Nagai N, Dohi Y Ohgushi H. BMP-induced osteogenesis on the surface of hydroxyapatite with geometrically feasible and nonfeasible structures: topology of osteogenesis. J Biomed Mater Res 1998;39:190-199.
39. Mori S, Yoshikawa H, Hashimoto J, Ueda T, Funai H, Kato M, Takaoka K. Antiangiogenic agent (TNP-470) inhibition of ectopic bone formation induced by bone morphogenetic protein-2. Bone 1998;22:99-105.
40. Reddi AH, Cunningham NS. Isolation and promotion of bone differentiation by bone morphogenetic proteins. J Bone Miner Res 1993;(Suppl 2):S499-S502.